Display options
Cite
Müller-Richter UD, Dowejko A, Driemel O, et al. Impact of MAGE-A antigens on taxane response in oral squamous cell carcinoma. Oncol Lett. 2010;1(1):181-185doi: 10.3892/ol_00000033.
Müller-Richter, U. D., Dowejko, A., Driemel, O., Reuther, T., Reichert, T. E., & Kübler, A. C. (2010). Impact of MAGE-A antigens on taxane response in oral squamous cell carcinoma. Oncology letters, 1(1), 181-185. https://doi.org/10.3892/ol_00000033
Müller-Richter, Urs D A, et al. "Impact of MAGE-A antigens on taxane response in oral squamous cell carcinoma." Oncology letters vol. 1,1 (2010): 181-185. doi: https://doi.org/10.3892/ol_00000033
Müller-Richter UD, Dowejko A, Driemel O, Reuther T, Reichert TE, Kübler AC. Impact of MAGE-A antigens on taxane response in oral squamous cell carcinoma. Oncol Lett. 2010 Jan;1(1):181-185. doi: 10.3892/ol_00000033. Epub 2010 Jan 01. PMID: 22966279; PMCID: PMC3436363.
Copy Download .nbib Format: NLM
Share it on

Oncol Lett. 2010 Jan;1(1):181-185. doi: 10.3892/ol_00000033. Epub 2010 Jan 01.

Impact of MAGE-A antigens on taxane response in oral squamous cell carcinoma.

Oncology letters

Urs D A Müller-Richter, Albert Dowejko, Oliver Driemel, Tobias Reuther, Torsten E Reichert, Alexander C Kübler

Affiliations

  1. Department of Oral and Maxillofacial Plastic Surgery, University Hospital Würzburg, 97070 Würzburg.

PMID: 22966279 PMCID: PMC3436363 DOI: 10.3892/ol_00000033

Abstract

MAGE-A antigens are a subgroup of cancer/testis antigens that are exclusively expressed in malignant cells. Only scarce information on the function of MAGE-A antigens is available. There is some evidence that they may influence the response to chemotherapeutic drugs. This study aimed to evaluate the impact of the MAGE-A antigen subgroups MAGE-A2, -A3, -A4 and -A6 on oral squamous cell carcinoma cell lines treated with docetaxel and paclitaxel. Five oral squamous cell carcinoma cell lines were characterized for their quantitative expression of MAGE-A2, -A3, -A4 and -A6. The cell lines were treated with concentrations ranging from 0.025 to 0.8 μM of docetaxel and paclitaxel. The amount of viable cells after 24 and 48 h was measured. The measurements were statistically correlated with MAGE-A expression. All cell lines responded to docetaxel and paclitaxel. One cell line showed a statistically significant weaker response to the taxane treatment. This cell line was the only one that expressed MAGE-A4. MAGE-A4 has a statistically significant impact on the tumour response to docetaxel and paclitaxel in oral squamous cell carcinoma. This may influence treatment options and the course of the disease. Therefore, patients should be evaluated for MAGE-A4 expression before treatment with taxanes.

References

  1. Head Face Med. 2009 Apr 09;5:10 - PubMed
  2. Oral Oncol. 2008 Jul;44(7):628-33 - PubMed
  3. Anticancer Res. 2006 Mar-Apr;26(2B):1513-8 - PubMed
  4. Head Neck. 2006 Jul;28(7):614-9 - PubMed
  5. Oncol Rep. 2007 Aug;18(2):329-36 - PubMed
  6. Exp Cell Res. 2001 May 1;265(2):185-94 - PubMed
  7. World J Gastroenterol. 2004 Jul 1;10(13):1849-53 - PubMed
  8. Biochemistry. 1993 Mar 23;32(11):2747-55 - PubMed
  9. Clin Cancer Res. 2003 Jul;9(7):2778-85 - PubMed
  10. Acta Otolaryngol. 1996 Jul;116(4):633-9 - PubMed
  11. J Neurosurg Pediatr. 2008 Apr;1(4):305-13 - PubMed
  12. J Oral Pathol Med. 2008 Feb;37(2):88-93 - PubMed
  13. Anticancer Drugs. 1992 Apr;3(2):121-4 - PubMed
  14. Int J Cancer. 2000 Feb 15;85(4):460-5 - PubMed
  15. Int J Cancer. 1999 Nov 26;83(5):664-9 - PubMed
  16. Int J Oncol. 2005 Mar;26(3):817-24 - PubMed

Publication Types